Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI Releases RFAs for $1,000 Genome

NEW YORK, Feb. 13 (GenomeWeb News) - The National Human Genome Research Institute today released two RFAs aimed at reducing the costs of sequencing a single, full-length mammalian genome to $1,000 - down from current average costs of $10 to $50 million per genome - by the end of a 10-year time frame.

 

One RFA will commit $6 million in FY2004 and $5 million in FY2005 to fund new or competitive continuation grants for the long-range development of new technologies that could meet the $1,000 goal. The other RFA will commit $8 million in FY2004 and $5 million in FY2005 to fund new or competitive continuation grants for shorter term goals of improving existing technologies to reduce costs by two orders of magnitude below current costs. Respondents to both RFAs can apply under the R21, R33, R01 or P01 granting mechanisms, with deadlines of April 15 and Oct. 15, 2004.

 

The RFAs gave several potential applications of cost reduction efforts, including: expanding comparative genomic analysis across species, applying human genetic variation studies to individual health care, and analyzing microbial genomes for food and environment monitoring.

 

The Scan

Test of the China Initiative

According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

Collaborative Approach

A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.

Genes of a Guide Dog

Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.

PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing

In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.